NORGES BANK - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.

Quarter-by-quarter ownership
NORGES BANK ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$95,808,523
+8.8%
633,780
+4.9%
0.02%
+8.7%
Q2 2022$88,020,351
+53.9%
604,079
+25.3%
0.02%
+91.7%
Q1 2022$57,176,233
+3.0%
482,215
+19.7%
0.01%
+9.1%
Q4 2021$55,500,000
+1.7%
402,732
+2.5%
0.01%
-8.3%
Q3 2021$54,579,000
+35.7%
392,909
-5.2%
0.01%
+33.3%
Q2 2021$40,232,000
+47.9%
414,423
+4.1%
0.01%
+50.0%
Q1 2021$27,199,000
-37.5%
397,939
-21.6%
0.01%
-40.0%
Q4 2020$43,510,000
+37.1%
507,638
+4.0%
0.01%
+25.0%
Q3 2020$31,742,000
-15.4%
488,268
-4.9%
0.01%
-27.3%
Q2 2020$37,542,000
+117.9%
513,505
+1.4%
0.01%
+83.3%
Q1 2020$17,232,000
-34.1%
506,370
+5.4%
0.01%
-14.3%
Q4 2019$26,154,000
+39.1%
480,421
+6.6%
0.01%
+16.7%
Q3 2019$18,807,000
-4.7%
450,8030.0%0.01%0.0%
Q2 2019$19,741,000
+226.4%
450,803
+283.6%
0.01%
+200.0%
Q1 2019$6,048,000
+348.3%
117,510
+135.0%
0.00%
Q4 2017$1,349,000
-27.8%
50,0000.0%0.00%
-100.0%
Q3 2017$1,869,000
+49.5%
50,0000.0%0.00%
Q2 2017$1,250,00050,0000.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q3 2021
NameSharesValueWeighting ↓
RP Management, LLC 1,111,111$154,344,00072.03%
Knoll Capital Management, LLC 856,844$119,024,00059.36%
ORACLE INVESTMENT MANAGEMENT INC 2,124,055$295,053,00036.73%
ARS Investment Partners, LLC 466,668$64,825,0006.49%
KINGDON CAPITAL MANAGEMENT, L.L.C. 365,373$50,754,0006.18%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 176,400$24,490,0005.91%
SILVERARC CAPITAL MANAGEMENT, LLC 61,897$8,598,0004.86%
DAFNA Capital Management LLC 88,100$12,238,0003.25%
Avidity Partners Management LP 934,200$129,770,0002.88%
Eventide Asset Management 1,325,000$184,056,0002.43%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders